Aug. 23 at 9:37 PM
$MNKD 👀😲👀🤑👍
APPROVALS {and eventual accretive} ADDS TO
$MNKD SHARE PRICE [B4 EOY 2028]:
+
$4 -- acquisition of scPharma [
$SCPH ]
+
$4 -- label change - Afrezza
+
$1 -- Afrezza in India
+
$6 -- pediatric Afrezza
+
$8 -- FDA approval of Furoscix auto injector
+
$2 -- gestational Afrezza
+
$6 -- Ralinepag DPI [MNKD-1501
$UTHR ]
+
$8 -- Nintedanib DPI [MNKD-201]
+
$3 -- Bumetanide DPI [MNKD-701]
+
$6 -- Tyvaso DPI bridge for IPF & PPF
+ $? -- Undisclosed drug
+ $? -- Clofazimine DPI
--------
+
$48/sh
👀
$SPY 🇺🇲
$QQQ 👍
